Literature DB >> 32281926

COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).

Marco Marietta1, Walter Ageno2, Andrea Artoni3, Erica De Candia4,5, Paolo Gresele6, Marina Marchetti7, Rossella Marcucci8, Armando Tripodi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32281926      PMCID： PMC7250682          DOI： 10.2450/2020.0083-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  23 in total

Review 1.  The role of heparin in sepsis: much more than just an anticoagulant.

Authors:  Xu Li; Xiaochun Ma
Journal:  Br J Haematol       Date:  2017-08-18       Impact factor: 6.998

2.  Identifying Sepsis Populations Benefitting from Anticoagulant Therapy: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.

Authors:  Kazuma Yamakawa; Satoshi Gando; Hiroshi Ogura; Yutaka Umemura; Daijiro Kabata; Ayumi Shintani; Atsushi Shiraishi; Daizoh Saitoh; Seitato Fujishima; Toshihiko Mayumi; Shigeki Kushimoto; Toshikazu Abe; Yasukazu Shiino; Taka-Aki Nakada; Takehiko Tarui; Toru Hifumi; Yasuhiro Otomo; Kohji Okamoto; Joji Kotani; Yuichiro Sakamoto; Junichi Sasaki; Shin-Ichiro Shiraishi; Kiyotsugu Takuma; Ryosuke Tsuruta; Akiyoshi Hagiwara; Tomohiko Masuno; Naoshi Takeyama; Norio Yamashita; Hiroto Ikeda; Masashi Ueyama; Satoshi Fujimi
Journal:  Thromb Haemost       Date:  2019-08-13       Impact factor: 5.249

Review 3.  Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms.

Authors:  Shaun P Jackson; Roxane Darbousset; Simone M Schoenwaelder
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

Review 4.  The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.

Authors:  Ryan Zarychanski; Ahmed M Abou-Setta; Salmaan Kanji; Alexis F Turgeon; Anand Kumar; Donald S Houston; Emily Rimmer; Brett L Houston; Lauralyn McIntyre; Alison E Fox-Robichaud; Paul Hébert; Deborah J Cook; Dean A Fergusson
Journal:  Crit Care Med       Date:  2015-03       Impact factor: 7.598

Review 5.  Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.

Authors:  T Iba; J H Levy
Journal:  J Thromb Haemost       Date:  2017-12-21       Impact factor: 5.824

6.  D-dimer is a significant prognostic factor in patients with suspected infection and sepsis.

Authors:  Joaquín R Rodelo; Gisela De la Rosa; Martha L Valencia; Sigifredo Ospina; Clara M Arango; Carlos I Gómez; Alex García; Edilberto Nuñez; Fabián A Jaimes
Journal:  Am J Emerg Med       Date:  2012-07-15       Impact factor: 2.469

7.  ISTH interim guidance on recognition and management of coagulopathy in COVID-19.

Authors:  Jecko Thachil; Ning Tang; Satoshi Gando; Anna Falanga; Marco Cattaneo; Marcel Levi; Cary Clark; Toshiaki Iba
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

Review 8.  Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.

Authors:  Amir Emami; Fatemeh Javanmardi; Neda Pirbonyeh; Ali Akbari
Journal:  Arch Acad Emerg Med       Date:  2020-03-24

9.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272
View more
  123 in total

Review 1.  Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach.

Authors:  Raquel López-Reyes; Grace Oscullo; David Jiménez; Irene Cano; Alberto García-Ortega
Journal:  Arch Bronconeumol       Date:  2020-08-31       Impact factor: 4.872

2.  Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.

Authors:  Marco Cattaneo; Nuccia Morici
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

3.  COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

Authors:  Antonio Coppola; Maria Lombardi; Maria I Tassoni; Gaetano Carolla; Maurizio Tala; Rossella Morandini; Oriana Paoletti; Sophie Testa
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

4.  Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".

Authors:  Marco Marietta; Armando Tripodi
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

5.  The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations, and Treatment Recommendations.

Authors:  S Louw; B F Jacobson; E S Mayne; T M Wiggill
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Multisystemic Infarctions in COVID-19: Focus on the Spleen.

Authors:  Mariana Santos Leite Pessoa; Carla Franco Costa Lima; Ana Carla Farias Pimentel; José Carlos Godeiro Costa; Jorge Luis Bezerra Holanda
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-03

7.  Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes.

Authors:  F D'Amore; G Vinacci; E Agosti; L P Cariddi; A V Terrana; F A Vizzari; M Mauri; A Giorgianni
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

8.  Risk of peripheral arterial thrombosis in COVID-19.

Authors:  Gaspar Mestres; Roger Puigmacià; Carla Blanco; Xavier Yugueros; Montserrat Esturrica; Vincent Riambau
Journal:  J Vasc Surg       Date:  2020-05-07       Impact factor: 4.268

Review 9.  SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.

Authors:  Stefano Burgio; Everly Conway de Macario; Alberto Jl Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2021-05-11       Impact factor: 3.667

10.  Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases.

Authors:  Falmata Laouan Brem; Zakariae Missaoui; Mohammed Arghal; Hammam Rasras; Narjisse Aichouni; Imane Skiker; Noha El Ouafi; Bazid Zakaria
Journal:  Pan Afr Med J       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.